Skip to main content
. 2024 Jan 3;67(1):E1–E6. doi: 10.1503/cjs.003722

Table 2.

Cost range for 90 days for all peripheral artery disease medical therapy options in each guideline-recommended12 drug class*

Drug class Cost, $ Cost difference, $
Lowest-cost agent* Highest-cost agent*
Angiotensin-converting-enzyme inhibitors 7.94 (generic ramipril) 747.00 (brand-name lisinopril) 739.06
Angiotensin receptor blockers 15.54 (generic valsartan) 452.70 (brand-name valsartan) 437.16
Antiplatelet agents 10.35 (generic ASA) 384.03 (brand-name clopidogrel) 373.68
Direct factor Xa inhibitors 129.15 (brand-name rivaroxaban) Only 1 agent available
Statins 19.71 (generic rosuvastatin) 384.30 (brand-name atorvastatin) 364.59

ASA = acetylsalicylic acid.

*

Cost represents that of the maximum evidence-based dosage of each drug and does not include dispensing or shipping fees.